MALT1 and B-cell chronic lymphocytic leukemia: Dual inhibition of SHP-2 (a tyrosine phosphatase upstream of ERK) and MALT1 has shown synergistic suppression of CLL cell survival, particularly in venetoclax-resistant clones [121,122].